Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,213
Total Claims
$1.2M
Drug Cost
454
Beneficiaries
$2,552
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-55%
Opioid rate vs peers
1.0% vs 2.2% avg
+81%
Cost per patient vs peers
$2,552 vs $1,411 avg
+79%
Brand preference vs peers
19.0% vs 10.6% avg
Opioid Prescribing
1.0%
Opioid Rate
133
Opioid Claims
$3,748
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,511 claims · $763K
Generic: 10,685 claims · $394K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rifaximin | 83 | $125K |
| Apixaban | 396 | $117K |
| Rivaroxaban | 164 | $49K |
| Insulin Detemir | 113 | $41K |
| Lipase/Protease/Amylase | 55 | $38K |
| Dextromethorphan Hbr/Quinidine | 62 | $32K |
| Collagenase Clostridium Hist. | 13 | $32K |
| Linaclotide | 33 | $18K |
| Ipratropium/Albuterol Sulfate | 29 | $15K |
| Potassium Chloride | 359 | $15K |
| Empagliflozin | 27 | $13K |
| Insulin Detemir | 45 | $12K |
| Pantoprazole Sodium | 246 | $12K |
| Lipase/Protease/Amylase | 21 | $11K |
| Lurasidone Hcl | 13 | $11K |
Prescribing Profile
Patient Profile
71
Avg Age
52%
Female
2.90
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data